Seminar to focus on strategies to improve HPV vaccination rates
BACKGROUND: Human papilloma virus, or HPV, is the most common sexually transmitted virus in the United States, with an estimated 79 million Americans currently infected. HPV can cause cervical cancer, as well as other forms of cancer. Fortunately, a vaccine exists that can reduce the risk of these cancers, but only if given before a person is infected. The American Academy of Pediatrics recommends routine HPV vaccination of both boys and girls at 11-12 years of age. The vaccine is most effective if administered before the onset of sexual activity, and antibody responses to the vaccine are highest at ages 9 through 15 years. However, HPV vaccination rates are much lower than other routinely recommended adolescent vaccines.
The Texas Pediatrics Society is sponsoring a seminar for physicians and health professionals on HPV and vaccination, hosted by University Health System. Topics will include HPV and associated cancers, vaccine recommendations for boys and girls, the safety and effectiveness of the vaccine and strategies to improve vaccination rates. A program can be found at Texas Pediatric Society.
Dr. Melinda Wharton, Centers for Disease Control and Prevention
Dr. Lois Ramondetta, MD Anderson Cancer Center and LBJ General Hospital, Harris County Hospital District
Dr. Sharon Humiston, University of Missouri-Kansas City School of Medicine and Children’s Mercy Hospital
Half-day seminar on HPV cancers and vaccination
Friday, Feb. 26, 11 a.m. to 4 p.m.
Robert B. Green Campus clinical building, 903 W. Martin St., fifth-floor Foundation Room.
News organizations wishing to cover all or part of the seminar should call or email one of the media representatives above in advance.